83526-55-0

Basic information

• Product Name: (R)-1-O-octadecyl-3-(p-toluenesulfonyl)-glycerol
• Synonyms: (R)-1-O-octadecyl-3-(p-toluenesulfonyl)-glycerol
• CAS NO: 83526-55-0
• Molecular Weight: 498.768
• Mol File: 83526-55-0.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (R)-1-O-octadecyl-3-(p-toluenesulfonyl)-glycerol(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-1-O-octadecyl-3-(p-toluenesulfonyl)-glycerol(83526-55-0)
• EPA Substance Registry System: (R)-1-O-octadecyl-3-(p-toluenesulfonyl)-glycerol(83526-55-0)

Safety Data

• Hazardous Substances Data: 83526-55-0(Hazardous Substances Data)

Upstream product

• 83167-57-1 3-O-Benzyl-1-O-octadecyl-sn-glycerol 
• 83526-60-7 2-O-Acetyl-1-O-benzyl-3-O-octadecyl-sn-glycerin 
• 83526-52-7 3-O-Octadecyl-2-O-p-toluolsulfonyl-sn-glycerin 
• 83526-54-9 3-O-Octadecyl-1-O-p-toluolsulfonyl-sn-glycerin 
• 83537-01-3 (-)-1-O-octadecyl-2-O-acetyl-sn-glycerol 
• 83526-56-1 (S)-1,2-Epoxy-3-(octadecyloxy)propan 
• 83526-51-6 3-O-Octadecyl-2-O-p-toluolsulfonyl-3-O-trityl-sn-glycerin 
• 83526-50-5 3-O-Octadecyl-1,2-di-O-p-toluolsulfonyl-sn-glycerin 
• 80707-96-6 Ro 15-4454 
• 83526-57-2 (S)-1-(benzyloxy)-3-(octadecyloxy)propan-2-ol 
• 83526-53-8 (R)-1,2-Epoxy-3-(octadecyloxy)propan 
• 6076-32-0 3-O-Octadecyl-1-O-trityl-sn-glycerin 
• 3386-32-1 n-octadecyl p-toluenesulfonate 
• 10152-41-7 1-O-octadecyl-2,3-diacetoyl-sn-glycerol 

Downstream Products

• 80483-86-9 2-O-Benzyl-1-O-octadecyl-sn-glycero-3-phosphorylcholin 
• 80707-93-3 (S)-1-O-octadecyl-2-O-benzyl-glycerol 
• 74430-89-0 Lyso-platelet-activating factor (C₁₈) 
• 918946-93-7 Phosphoric acid (R)-2-benzyloxy-3-octadecyloxy-propyl ester (S)-2,2-dimethyl-[1,3]dioxolan-4-ylmethyl ester methyl ester 
• 1026554-06-2 Phosphoric acid (R)-2-benzyloxy-3-octadecyloxy-propyl ester (S)-2,3-dihydroxy-propyl ester 
• 871693-93-5 (R)-1-O-octadecyl-2-O-benzyl-3-(p-toluenesulfonyl)glycerol 

Relevant articles and documents

Synthesis and biophysical characterization of chlorambucil anticancer ether lipid prodrugs

The synthesis and biophysical characterization of four prodrug ether phospholipid conjugates are described. The lipids are prepared from the anticancer drug chlorambucil and have C16 and C18 ether chains with phosphatidylcholine or phosphatidylglycerol he

Conformationally restricted analogs of platelet-activating factor (PAF)

-